1. Amgen Signs a Partnership with Adaptive Biotechnologies to Develop for COVID-19

Published: Apr 09, 2020 | Tags: Amgen, Adaptive Biotechnologies, Develop, Abs, COVID-19

2. ?? Samsung Biologics Signs an Agreement with Vir Biotechnology to Develop Abs for COVID-19

Published: Apr 09, 2020 | Tags: Samsung Biologics, Agreement, Vir Biotechnology, Abs, COVID-19

3. ?? Abbott’s TriClip Transcatheter Tricuspid Valve Repair System Receives the CE Mark for Minimally Invasive Tricuspid Valve Repair

Published: Apr 09, 2020 | Tags: Abbott,TriClip Transcatheter Tricuspid Valve Repair, CE Mark, Minimally Invasive Valve Repair

4. Cipla Receives FDA’s ANDA Approval for its HFA Inhalation Aerosol to Treat Acute Episodes of Bronchospasm or to Prevent Asthmatic Symptoms

Published: Apr 09, 2020 | Tags: Cipla, FDA, ANDA, HFA Inhalation, Aerosol, Acute Episodes, Bronchospasm, Prevent, Asthmatic, Symptoms

5. ? BMS Signs a Clinical Trial Collaboration with NeoImmune to Evaluate Opdivo (nivolumab) in Combination with NT-I7 (Hyleukin-7)

Published: Apr 09, 2020 | Tags: BMS, Signs, Clinical Trial Collaboration, NeoImmune, Opdivo, NT-17

6. Astellas Reports NMPA’s Acceptance of NDA for XOSPATA (gilteritinib) to Treat R/R AML with a FLT3 Mutation in Adults

Published: Apr 08, 2020 | Tags: Astellas, NMPA, NDA, XOSPATA, R/R, AML, Adults, FLT3 Mutation

7. ? Pfizer and BioNTech Provide Updates on its Collaboration for Global COVID-19 Vaccine

Published: Apr 08, 2020 | Tags: Pfizer, BioNTech, Provide, Updates, Collaboration, Global, Covid-19 Vaccine

8. Global Pharmaceuticals and the University of Cambridge Collaborate to Launch a Laboratory for COVID-19 Testing

Published: Apr 08, 2020 | Tags: Two, Global Pharmaceuticals, University of Cambridge, Collaborate, Laboratory, COVID-19 Testing

9. EMD Serono and Pfizer’s Bavencio (avelumab) Receive the US FDA’s Breakthrough Therapy Designation as 1L Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

Published: Apr 08, 2020 | Tags: EMD Serono, Pfizer, Bavencio, avelumab, Receive, US, FDA, Breakthrough Therapy Designation, 1L, Maintenance Treatment, Locally Advanced, Metastatic Urothelial Carcinoma

10. Novavax Accelerates the Initiation of Clinical Study for NVX-CoV2373 to Mid-May 2020

Published: Apr 08, 2020 | Tags: Novavax, Accelerates, Initiation, Clinical Study, NVX-CoV2373, Mid-May 2028

11. Chugai Initiates P-III Clinical Study of Actemra for COVID-19 Pneumonia in Japan

Published: Apr 08, 2020 | Tags: Chugai, Initiates, P-III, Clinical Study, Actemra, COVID-19, Pneumonia, Japan

12. AstraZeneca Focuses on the Discovery of Monoclonal Antibodies Neutralizing SARS-CoV-2 Virus

Published: Apr 08, 2020 | Tags: AstraZeneca, Focuses, Discovery, Monoclonal Antibodies, Neutralizing, SARS-CoV-2 Virus

13. Roche Signs a License Agreement with Arrakis Therapeutics for the Discovery of RNA-Targeted Small Molecule Therapies

Published:  Apr 07, 2020 | Tags: Roche, Signs, License Agreement, Arrakis Therapeutics, Discovery, RNA-Targeted, Small Molecule, Therapies

14. Zai Lab Signs a Development and Commercialization Agreement with Regeneron for REGN1979 in Oncology

Published:  Apr 07, 2020 | Tags: Zai Lab, Signs, Development, Commercialization, Agreement, Regeneron, REGN1979, Oncology

15. Bayer Launches Eylea (aflibercept) Pre-Filled Syringe in Europe

Published: Apr 07, 2020 | Tags: Bayer, Launches, Eylea, aflibercept, Pre-Filled Syringe, Europe

16. ?? BMS Expands its Existing Patient Support Programs to Aid Uninsured Patients in the US Amid COVID-19

Published:  Apr 07, 2020 | Tags: BMS, Expands, Existing, Patient Support Program, Aid, Uninsured Patients, US, Amid, COVID-19

17. ?? Oxford Biomedica Joins Consortium to Develop ChAdOx1 nCov-19 for COVID-19

Published:  Apr 07, 2020 | Tags: Oxford Biomedica, Joins, Consortium, Develop, ChAdOx1 nCov-19, COVID-19

18. The US FDA Delays its Decision on Roche’s Risdiplam for the Treatment of Spinal Muscular Atrophy

Published: Apr 07, 2020 | Tags: US, FDA, Delays, Decision, Roche, Risdiplam, Treatment, Spinal Muscular Atrophy

19. Merck Receives the US FDA’s Priority Review for Keytruda’s (pembrolizumab) sBLA Based on Biomarker Regardless of Tumor Type

Published: Apr 07, 2020 | Tags: Merck, Receives, US, FDA, Priority Review, Keytruda, pembrolizumab, sBLA, Based, Biomarker, Regardless of Tumor Type

20. CytoDyn Collaborates with UK’s Department of Health to Provide Emergency Access to Leronlimab (PRO 140) for Patients with COVID-19

Published:  Apr 07, 2020 | Tags:  CytoDyn, Collaborates, UK, Department of Health, Provide, Emergency Access, Leronlimab, PRO 140, Patients, COVID-19

21. Takeda’s Alunbrig (brigatinib) Receives EC’s Approval as a 1L Treatment for ALK+ Advanced Non-Small Cell Lung Cancer

Published: Apr 07, 2020 | Tags:  Takeda, Alunbrig, brigatinib, Receives, EC, Approval, 1L, Treatment, ALK+, Advanced Non-Small Cell Lung Cancer

22. ??? GSK Collaborates with Vir to Develop Treatment for COVID-19

Published: Apr 06, 2020 | Tags: GSK, Collaborates, Vir, Develop, Treatment, COVID-19

23. Alnylam and Dicerna Collaborate to Develop and Commercialize RNAi Therapeutics for Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

Published: Apr 06, 2020 | Tags: Alnylam, Dicerna, Collaborate, Develop, Commercialize, RNAi Therapeutics, Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

24. Sanofi and Regeneron Finalizes the Restructuring of Their Collaboration on Praluent (alirocumab)

Published: Apr 06, 2020 | Tags: Sanofi, Regeneron, Restructure, Collaboration, Praluent, alirocumab

25. Takeda Signs a Multi-Year Research Collaboration with Evotec to Expedite Research Program Across its Core Therapeutic Areas

Published: Apr 06, 2020 | Tags: Takeda, Signs, Multi-Year, Research Collaboration, Evotec, Expedite, Research Program, Core, Therapeutic Areas

26. Gilead Sciences and Second Genome Signs a Four-Year Collaboration to Identify Biomarkers and Therapies Targeting Inflammatory Bowel Disease

Published: Apr 06, 2020 | Tags: Gilead Sciences, Second Genome, Signs, Four-Year Collaboration, Identify Biomarkers, Therapies, Targeting, Inflammatory Bowel Disease

27. Janssen Signs a Worldwide Collaboration with Fate Therapeutics for Novel iPSC-Derived Cell-Based Cancer Immunotherapies

Published: Apr 02, 2020 | Tags: Janssen, Signs, Worldwide, Collaboration, Fate Therapeutics, Novel, iPSC-Derived, Cell-Based, Cancer Immunotherapies

28. EMA’s CHMP Recommends Compassionate Use of Gilead’s Remdesivir for COVID-19

Published: Apr 03, 2020 | Tags: EMA, CHMP, Recommends, Compassionate Use, Gilead, Remdesivir, COVID-19

29. GSK Collaborates with Innovax to Evaluate a Vaccine Against COVID-19 Pandemic

Published: Apr 05, 2020 | Tags: GSK, Collaborates, Innovax, Evaluate, Vaccine, Against, COVID-19, Pandemic